HR Execs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

AbboMax

AbboMax is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Our Lady of the Valley Retirement Community

Our Lady of the Valley is a non-profit, non-denominational senior living community that provides assisted living, long term nursing, and skilled rehabilitation care. They strive to enhance the quality of life for their senior living residents through p...

Sobi North America

Sobi is an international specialty healthcare company dedicated to developing treatments and extensive patient support networks for people with rare and difficult to treat diseases. These patients are often misunderstood, misdiagnosed and have limited medical options otherwise. This commitment has led to our world-class capabilities in protein biochemistry and biologics manufacturing, recognized by our leading industry partners.

WellDyne

WellDyne is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innovative Health Applications

Innovative Health Applications is a Cape Canaveral, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.